Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Richter's Transformation × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 15 Recurrence 7 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, T-Cell, Peripheral 3 Glioblastoma 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Sarcoma 2 Primary Myelofibrosis 2 Neoplasms 2 Melanoma 2 Lymphoma, T-Cell, Cutaneous 2 Carcinoma, Squamous Cell 2 Waldenstrom Macroglobulinemia 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Neoplasms 1 Richter's Transformation 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms, Plasma Cell 1 Neoplasms by Site 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Liposarcoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02138786 2023-01-26

SIRRT

Karyopharm Therapeutics Inc

Phase 2 Terminated

27 enrolled 17 charts

Richter's Transformation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡